<DOC>
	<DOCNO>NCT01476761</DOCNO>
	<brief_summary>The purpose study evaluate safety Microcutter staple /cutting device patient require transection , resection anastomosis gastrointestinal tissue post-market approval study .</brief_summary>
	<brief_title>MicroCutter Surgical Stapling - European Trial I</brief_title>
	<detailed_description>A prospective , open label , multi-center non-inferiority safety study all-comers enrollment patient require surgical stapling stomach and/or intestine accord label indication contain approved labeling . Up 178 subject consent 1-month clinical follow-up evaluation enrol . Primary endpoint statistical non-inferiority composite major adverse event rate ( composite infection ( non-dermal ) , dehiscence , bleeding , stricture ) study patient compare composite major adverse event rate ( composite infection ( non-dermal ) , dehiscence , bleeding , stricture ) derive comprehensive analysis medical literature . The comparison perform cumulative event 30 day postoperatively .</detailed_description>
	<criteria>All patient require surgical treatment use surgical stapler anticipate None</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>Surgical tissue resection</keyword>
	<keyword>Tissue dissection</keyword>
	<keyword>Tissue transection</keyword>
	<keyword>Anastomosis gastrointestina tissue</keyword>
</DOC>